MoziforĀ® (Plerixafor Injection USP 24mg/1.2ml, 20mg/ml) is a prescription injection used with G-CSF to mobilize hematopoietic stem cells for collection and transplantation in eligible patients. Use under medical supervision.
MoziforĀ® (Plerixafor Injection USP 24mg/1.2ml)
It is a prescription medication that helps mobilize hematopoietic stem cells into the bloodstream for collection and autologous transplantation. Healthcare professionals commonly use it alongside granulocyte-colony stimulating factor (G-CSF). In addition, doctors may prescribe it for eligible patients with multiple myeloma and non-Hodgkin lymphoma.
Key Features
ā Contains Plerixafor 24mg/1.2ml (20mg/ml)
ā Supports stem cell mobilization
ā Works effectively with G-CSF therapy
ā Sterile injectable solution
ā Produced under strict quality standards
Indications
MoziforĀ® helps move hematopoietic stem cells into the peripheral blood for collection and transplantation. Therefore, it plays an important role in stem cell transplant procedures when prescribed by a healthcare professional.
Dosage & Administration
A qualified healthcare provider should administer this medication. Furthermore, the physician determines the appropriate dosage based on the patient’s condition and treatment plan.
Storage
Store according to the manufacturer’s instructions. Also, keep the product out of reach of children.
Important Safety Information
Use this product only under medical supervision. Before starting treatment, consult your doctor or pharmacist for complete prescribing information, warnings, contraindications, and possible side effects.
Related products
KemocarbĀ® (Carboplatin IP 150mg/15ml) is a platinum-based chemotherapy injection used in the treatment of various cancers, including ovarian, lung, breast, and cervical cancers. It helps slow or stop the growth of cancer cells and is administered by healthcare professionals under specialist supervision.
